Even the best stock pickers will make plenty of bad investments. Anyone who held Kura Oncology, Inc. (NASDAQ:KURA) over the last year knows what a loser feels like. The share price is down a hefty 64% ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Come for the presents. Stay for the baggage.

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

Kura Corp stock price live, this page displays TYO 2695 stock exchange data. View the 2695 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest ...

Fintel reports that on November 24, 2025, Barclays maintained coverage of Kura Oncology (NasdaqGS:KURA) with a Overweight recommendation. Analyst Price Forecast Suggests 182.25% Upside As of November ...

Kura Oncology is rated Buy, driven by a strong cash position, strategic Kyowa Kirin partnership, and a robust, diversified pipeline. KURA's lead asset, Ziftomenib, targets AML and awaits a pivotal FDA ...